Financial Counselors Inc’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-8,745
Closed -$980K 215
2025
Q1
$980K Sell
8,745
-142
-2% -$14.7K 0.01% 339
2024
Q4
$821K Buy
8,887
+274
+3% +$24.7K 0.01% 356
2024
Q3
$722K Sell
8,613
-1,390
-14% -$106K 0.01% 382
2024
Q2
$686K Buy
10,003
+111
+1% +$7.41K 0.01% 363
2024
Q1
$725K Buy
9,892
+1,030
+12% +$79.2K 0.01% 365
2023
Q4
$718K Buy
8,862
+128
+1% +$9.96K 0.01% 358
2023
Q3
$655K Sell
8,734
-281
-3% -$21.6K 0.01% 360
2023
Q2
$695K Sell
9,015
-556
-6% -$44.3K 0.01% 330
2023
Q1
$794K Sell
9,571
-488
-5% -$40.4K 0.02% 318
2022
Q4
$864K Sell
10,059
-283
-3% -$22.4K 0.02% 314
2022
Q3
$638K Sell
10,342
-659
-6% -$41.6K 0.02% 331
2022
Q2
$680K Buy
11,001
+793
+8% +$49.1K 0.02% 329
2022
Q1
$607K Buy
10,208
+103
+1% +$6.58K 0.01% 343
2021
Q4
$734K Sell
10,105
-342
-3% -$23.6K 0.02% 333
2021
Q3
$730K Sell
10,447
-1,755
-14% -$123K 0.02% 335
2021
Q2
$840K Buy
12,202
+5,836
+92% +$390K 0.02% 325
2021
Q1
$411K Sell
6,366
-516
-7% -$33.3K 0.01% 386
2020
Q4
$401K Sell
6,882
-341
-5% -$20.6K 0.01% 391
2020
Q3
$456K Sell
7,223
-1,709
-19% -$119K 0.01% 348
2020
Q2
$687K Buy
8,932
+1,308
+17% +$100K 0.02% 328
2020
Q1
$570K Buy
7,624
+22
+0.3% +$1.52K 0.03% 292
2019
Q4
$494K Sell
7,602
-3,690
-33% -$240K 0.02% 350
2019
Q3
$716K Buy
11,292
+3,004
+36% +$196K 0.03% 304
2019
Q2
$560K Sell
8,288
-1,844
-18% -$121K 0.02% 321
2019
Q1
$659K Buy
10,132
+1,255
+14% +$83.4K 0.03% 306
2018
Q4
$555K Sell
8,877
-1,326
-13% -$92.7K 0.03% 313
2018
Q3
$788K Sell
10,203
-1,456
-12% -$110K 0.03% 301
2018
Q2
$826K Buy
11,659
+2,624
+29% +$185K 0.04% 291
2018
Q1
$681K Sell
9,035
-2,298
-20% -$183K 0.03% 307
2017
Q4
$812K Sell
11,333
-760
-6% -$57.7K 0.04% 298
2017
Q3
$980K Buy
12,093
+13
+0.1% +$994 0.05% 275
2017
Q2
$855K Sell
12,080
-730
-6% -$48.6K 0.04% 296
2017
Q1
$870K Buy
12,810
+3,935
+44% +$277K 0.04% 294
2016
Q4
$636K Buy
+8,875
New +$660K 0.03% 311
2016
Q2
$558K Buy
6,695
+255
+4% +$22.6K 0.03% 308
2016
Q1
$592K Sell
6,440
-64,032
-91% -$5.77M 0.04% 297
2015
Q4
$7.13M Sell
70,472
-483
-0.7% -$50.3K 0.46% 68
2015
Q3
$6.97M Buy
70,955
+2,612
+4% +$290K 0.48% 67
2015
Q2
$8M Buy
68,343
+129
+0.2% +$14.1K 0.51% 58
2015
Q1
$6.69M Sell
68,214
-7,735
-10% -$785K 0.42% 81
2014
Q4
$7.16M Buy
75,949
+46,468
+158% +$4.81M 0.45% 70
2014
Q3
$3.14M Buy
29,481
+11,652
+65% +$1.14M 0.22% 142
2014
Q2
$1.48M Sell
17,829
-2,987
-14% -$233K 0.1% 213
2014
Q1
$1.48M Buy
20,816
+1,791
+9% +$140K 0.11% 216
2013
Q4
$1.43M Buy
19,025
+4,332
+29% +$302K 0.11% 193
2013
Q3
$924K Buy
14,693
+2,500
+21% +$149K 0.08% 236
2013
Q2
$625K Buy
+12,193
New +$636K 0.05% 263

Other funds holding GILD

Financial Counselors Inc's GILD Position: Q2 2025 in Review

Financial Counselors Inc sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 8,745 shares — an estimated $980K sold.

Financial Counselors Inc first reported a position in GILD in Q2 2013 and held it in 47 quarters. The position peaked at $8M in Q2 2015. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Financial Counselors Inc reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Financial Counselors Inc sold 8,745 Gilead Sciences shares in Q2 2025, an estimated $980K.
  • Financial Counselors Inc first reported a position in Gilead Sciences in Q2 2013 and held it in 47 quarters.
  • Financial Counselors Inc's Gilead Sciences position peaked at $8M in Q2 2015.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Financial Counselors Inc's 13F filing for Q2 2025, filed 1 Aug 2025.